| |
|
|
| |
|
|
| |
HUM-MOLGEN
-> Events
-> Courses and Workshops |
|
|
| |
FDA's Vision for Interactions with Counterpart Regulators around the World | |
| |
November 15, 2007 |
|
|
| |
|
|
| |
|
|
|
Drug Information Association, Online
Dec 10 2007
Understanding FDA’s New Approach to Protecting Public Health WEBINAR HIGHLIGHTS The discovery, development, manufacturing, authorization, marketing, and use of pharmaceutical products have gone global. As a result, FDA has changed its approach to protecting and promoting public health. This new approach recognizes borders as boundaries, rather than as barriers to illness, product movement, and knowledge. As such, FDA interactions with global regulators continue to grow. This webinar will discuss FDA’s vision for continued interactions with counterpart regulators and how these new interactions will affect future decisions.
|
|
|
|
|
|
|
|
Organized by:
|
|
Drug Information Association |
|
|
Invited Speakers:
|
|
Murray M. Lumpkin, MDDeputy Commissioner (International and Special Programs)FDAUnited States.
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
http://www.diahome.org/DIAHOME/Education/FindEducationalOffering.aspx?productID=15542&eventType=Webinar
|
|
|
E-mail:
|
|
dia@diahome.org
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp,
Frank S.
Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved.
Liability, Copyright and Imprint. |
|